News Tag: English

Australian heart preservation study underway

  • 06:30

The first patient in an investigator-initiated heart preservation study using XVIVO’s technology was transplanted during the first quarter of 2021 at The Alfred hospital (Melbourne, Australia). The trial includes Australian and New Zealand transplant centers and is investigating if the novel preservation technology may safely extend the transport time for donor hearts, which is ideally limited to four hours using existing processes.

Read more

Conference call on Interim Report

  • 05:00

Invitation to attend XVIVO Perfusion’s conference call regarding the presentation of the interim report January – March 2021. The presentation will be held in English

Read more

Annual report 2020

  • 10:35

Today XVIVO Perfusion AB (publ) publish the Annual Report for 2020. The Annual Report is attached to this…

Read more

Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ)

  • 07:50

The shareholders in XVIVO Perfusion AB (publ), reg. no. 556561-0424 (the “Company” or “XVIVO”), with its registered office in Gothenburg, are hereby invited to the annual general meeting on Thursday 22 April 2021 at 15:00 AM, at The Swedish Exhibition & Congress Centre (Sw. Svenska Mässan) (conference room J2), at Mässans gata 24 in Gothenburg, Sweden.

Read more